Who owns ZIOPHARM Oncology?

Key details on ZIOPHARM Oncology (Ticker: ZIOP)

Who owns ZIOPHARM Oncology?

Is ZIOP a good stock to own? Find out who bought ZIOPHARM Oncology, who sold ZIOPHARM Oncology (ZIOP) stock, and who holds a large position in ZIOPHARM Oncology.

Fund Name Number of Shares Share Valuation As Of
University of Texas Investment Management Company 12.06M $144.75M June 30, 2015
Third Security 9.67M $115.99M June 30, 2015
STATE STREET CORPORATION 4.45M $53.44M June 30, 2015
MSDC Management 4.42M $47.66M March 31, 2015
Vanguard 4.21M $50.53M June 30, 2015
LMM 3.00M $32.31M March 31, 2015
BlackRock Fund Advisors 2.74M $32.88M June 30, 2015
Essex Woodlands Health Ventures 2.70M $13.69M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 2.66M $31.96M June 30, 2015
OrbiMed Advisors 2.54M $27.33M March 31, 2015
Belmont Global Advisors 2.27M $10.40M March 31, 2014
FMR 1.84M $22.08M June 30, 2015
SUSQUEHANNA INTERNATIONAL 1.84M $4.86M Sept. 30, 2014
Jennison Associates 1.52M $4.01M Sept. 30, 2014
MORGAN STANLEY 1.51M $18.17M June 30, 2015
Austin W. Marxe and David M. Greenhouse 1.11M $6.05M Sept. 30, 2012
NORTHERN TRUST 1.10M $13.20M June 30, 2015
Barclays 1.04M $4.15M March 31, 2014
GOLDMAN SACHS 1.03M $12.38M June 30, 2015
S.A.C. Capital Advisors 888000 $1.86M June 30, 2013
Visium Asset Management 827500 $3.44M Dec. 31, 2012

Who sold ZIOPHARM Oncology?

Fund Name Date Sold Number of Shares Sold Share Valuation
QVT Financial Sept. 30, 2011 936952 $4.13M
Baker Bros. Advisors Sept. 30, 2011 849500 $3.75M
Sunrise Partners Limited Partnership Dec. 31, 2010 1.21M $5.66M